SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-136560
Filing Date
2016-08-03
Accepted
2016-08-03 16:20:38
Documents
20
Period of Report
2016-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-16039_18k.htm 8-K 29512
2 EX-99.1 a16-16039_1ex99d1.htm EX-99.1 103336
3 EX-99.2 a16-16039_1ex99d2.htm EX-99.2 26938
4 GRAPHIC g160391mm01i001.gif GRAPHIC 1409
5 GRAPHIC g160391moi001.gif GRAPHIC 19769
6 GRAPHIC g160391moi002.gif GRAPHIC 183708
7 GRAPHIC g160391moi003.gif GRAPHIC 72344
8 GRAPHIC g160391moi004.gif GRAPHIC 21239
9 GRAPHIC g160391moi005.gif GRAPHIC 97014
10 GRAPHIC g160391moi006.gif GRAPHIC 121749
11 GRAPHIC g160391moi007.gif GRAPHIC 73368
12 GRAPHIC g160391moi008.gif GRAPHIC 45685
13 GRAPHIC g160391moi009.gif GRAPHIC 23393
14 GRAPHIC g160391moi010.gif GRAPHIC 61592
15 GRAPHIC g160391moi011.gif GRAPHIC 71175
16 GRAPHIC g160391moi012.gif GRAPHIC 12354
17 GRAPHIC g160391moi013.gif GRAPHIC 54226
18 GRAPHIC g160391moi014.gif GRAPHIC 53609
19 GRAPHIC g160391moi015.gif GRAPHIC 53202
20 GRAPHIC g160391moi016.gif GRAPHIC 81388
  Complete submission text file 0001104659-16-136560.txt   1601606
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36617 | Film No.: 161804127
SIC: 2834 Pharmaceutical Preparations